35Cl nuclear magnetic resonance line broadening shows that eosin-5-maleimide does not block the external anion access channel of band 3.
It has been suggested that Lys-430 of band 3, with which eosin-5-maleimide (EM) reacts, is located in the external channel through which anions gain access to the external transport site, and that EM inhibits anion exchange by blocking this channel. To test this, we have used 35Cl nuclear magnetic resonance (NMR) to measure Cl- binding to the external transport site in control and EM-treated human red blood cells. Intact cells were used rather than ghosts, because in this case all line broadening (LB) results from binding to external sites. In an NMR spectrometer with a 9.4-T magnetic field, red blood cells at 50% concentration (v/v) in 150 mM Cl- medium at 3 degrees C caused 19.0 +/- 1.2 Hz LB. Of this, 7.9 +/- 0.7 Hz was due to Cl- binding to the high affinity band 3 transport sites, because it was prevented by an apparently competitive inhibitor of anion exchange, 4,4'-dinitrostilbene-2,2'-disulfonate (DNDS). The LB was not due to hemoglobin released from the cells, as little LB remained in the supernatant after cells were removed by centrifugation. Saturable Cl- binding remained in EM-treated cells, although the binding was no longer DNDS-sensitive, because EM prevents binding of DNDS. The lower limit for the rate at which Cl- goes from the binding site to the external medium is 2.15 x 10(5) s-1 for control cells and 1.10 x 10(5) s-1 for EM-treated cells, far higher than the Cl- translocation rate at 3 degrees C (about 400 s-1). Thus, EM does not inhibit Cl- exchange by blocking the external access channel. EM may therefore be useful for fixing band 3 in one conformation for studies of Cl- binding to the external transport site.
Liu
D
D
Department of Biophysics, University of Rochester Medical Center, New York 14642, USA.
Kennedy
S D
SD
Knauf
P A
PA
D001457:Anion Exchange Protein 1, Erythrocyte / Q000737:chemistry / Q000187:drug effects*; D001665:Binding Sites; D001667:Binding, Competitive; D055592:Biophysical Phenomena; D001703:Biophysics; D002712:Chlorides / Q000737:chemistry; D004801:Eosine Yellowish-(YS) / Q000031:analogs & derivatives* / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000494:pharmacology*; D006400:Hematocrit; D006461:Hemolysis; D006801:Humans; D066298:In Vitro Techniques; D007454:Iodides / Q000737:chemistry; D007473:Ion Channels / Q000737:chemistry / Q000187:drug effects*; D007474:Ion Exchange; D009682:Magnetic Resonance Spectroscopy; D008956:Models, Chemical; D013267:Stilbenes / Q000494:pharmacology
D001457:Anion Exchange Protein 1, Erythrocyte; D002712:Chlorides; D005456:Fluorescent Dyes; D007454:Iodides; D007473:Ion Channels; D013267:Stilbenes; C022306:4,4'-dinitro-2,2'-stilbenedisulfonic acid; C033531:eosin maleimide; D004801:Eosine Yellowish-(YS)